BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 16575015)

  • 1. Peripheral neuropathy induced by microtubule-stabilizing agents.
    Lee JJ; Swain SM
    J Clin Oncol; 2006 Apr; 24(10):1633-42. PubMed ID: 16575015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of peripheral neuropathy caused by microtubule inhibitors.
    Donovan D
    Clin J Oncol Nurs; 2009 Dec; 13(6):686-94. PubMed ID: 19948466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epothilone-induced peripheral neuropathy: a review of current knowledge.
    Argyriou AA; Marmiroli P; Cavaletti G; Kalofonos HP
    J Pain Symptom Manage; 2011 Dec; 42(6):931-40. PubMed ID: 21621965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents.
    Argyriou AA; Zolota V; Kyriakopoulou O; Kalofonos HP
    J BUON; 2010; 15(3):435-46. PubMed ID: 20941808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced peripheral neuropathy.
    Hilkens PH; ven den Bent MJ
    J Peripher Nerv Syst; 1997; 2(4):350-61. PubMed ID: 10975744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-induced neuropathy.
    Windebank AJ; Grisold W
    J Peripher Nerv Syst; 2008 Mar; 13(1):27-46. PubMed ID: 18346229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy-induced peripheral neuropathy].
    Noguchi E; Maeda Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1773-6. PubMed ID: 22083183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.
    Hausheer FH; Schilsky RL; Bain S; Berghorn EJ; Lieberman F
    Semin Oncol; 2006 Feb; 33(1):15-49. PubMed ID: 16473643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
    Amara S
    Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the microtubules in breast cancer beyond taxanes: the epothilones.
    Cortes J; Baselga J
    Oncologist; 2007 Mar; 12(3):271-80. PubMed ID: 17405891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral neuropathy with microtubule-targeting agents: occurrence and management approach.
    Carlson K; Ocean AJ
    Clin Breast Cancer; 2011 Apr; 11(2):73-81. PubMed ID: 21569993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes.
    Mielke S; Sparreboom A; Mross K
    Eur J Cancer; 2006 Jan; 42(1):24-30. PubMed ID: 16293411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review on oxaliplatin-induced peripheral nerve damage.
    Argyriou AA; Polychronopoulos P; Iconomou G; Chroni E; Kalofonos HP
    Cancer Treat Rev; 2008 Jun; 34(4):368-77. PubMed ID: 18281158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of ixabepilone (BMS-247550), a novel epothilone B analogue].
    Villanueva C; Dufresne A; Pivot X; Viel E
    Bull Cancer; 2008 Feb; 95(2):197-204. PubMed ID: 18304905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy.
    Melli G; Taiana M; Camozzi F; Triolo D; Podini P; Quattrini A; Taroni F; Lauria G
    Exp Neurol; 2008 Dec; 214(2):276-84. PubMed ID: 18809400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice.
    Wickham R
    Clin J Oncol Nurs; 2007 Jun; 11(3):361-76. PubMed ID: 17623621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
    Wolf S; Barton D; Kottschade L; Grothey A; Loprinzi C
    Eur J Cancer; 2008 Jul; 44(11):1507-15. PubMed ID: 18571399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple myeloma, painful neuropathy, acupuncture?
    Zhou Y; Garcia MK; Chang DZ; Chiang J; Lu J; Yi Q; Romaguera J; Delasalle K; Guo Y; Forman A; Fang W; Wang M
    Am J Clin Oncol; 2009 Jun; 32(3):319-25. PubMed ID: 19887992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment.
    Tamburin S; Park SB; Alberti P; Demichelis C; Schenone A; Argyriou AA
    J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S40-S51. PubMed ID: 31647157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical development of ixabepilone and other epothilones in patients with advanced solid tumors.
    Rivera E; Lee J; Davies A
    Oncologist; 2008 Dec; 13(12):1207-23. PubMed ID: 19088324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.